insights_auto
Why is ALIVUS down 3,06%?
Dive Deeperchevron_right
ALIVUS:NSE
Alivus Life Sciences Ltd
₹1.337,10
arrow_downward
-3,06%(-42,20) 1D
1 ຕ.ລ., 13 ໂມງ 5 ນາທີ 20 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALIVUS...
Open
₹1.375,00
High
₹1.380,50
Low
₹1.317,20
Mkt. cap
164,16 ຕື້
Avg. vol.
167,55 ພັນ
Volume
55,80 ພັນ
Dividend
0,37%
Quarterly dividend
₹1,25
Ex-dividend date
1 ກ.ຍ. 2026
P/E ratio
27,27
52-wk high
₹1.493,80
52-wk low
₹819,00
EPS
₹49,03
No. of employees
2 ພັນ
Open
₹1.375,00
High
₹1.380,50
Low
₹1.317,20
Mkt. cap
164,16 ຕື້
Avg. vol.
167,55 ພັນ
Volume
55,80 ພັນ
Dividend
0,37%
Quarterly dividend
₹1,25
Ex-dividend date
1 ກ.ຍ. 2026
P/E ratio
27,27
52-wk high
₹1.493,80
52-wk low
₹819,00
EPS
₹49,03
No. of employees
2 ພັນ
News stories
From web sources and news partners
GuruFocus
·
24 ນາທີກ່ອນ
CollPlant Biotechnologies (CLGN) Reports Q3 Loss, Plans Strategi
Yahoo Finance
·
18 ນາທີກ່ອນ
Everpure Stock Is September’s Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In
TradingView
·
36 ນາທີກ່ອນ
Key facts: NASDAQ:ASTS Seeks Expanded Spectrum; Ships BlueBird
Seeking Alpha
·
1 ຊົ່ວໂມງກ່ອນ
Nasdaq rises nearly 2% in September, helped by late-month tech rally (AMD:NASDAQ)
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2,27 ພັນ
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com